Results 161 to 170 of about 3,740,437 (360)

Tentative standard methods of sampling and testing highway materials : adopted by the American Association of State Highway Officials and approved by the Secretary of Agriculture for use in connection with federal-aid road construction

, 1924

openalex   +2 more sources

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Advanced thermoplastic resins, phase 1 [PDF]

Eight thermoplastic polyimide resin systems were evaluated as composite matrix materials. Two resins were selected for more extensive mechanical testing and both were versions of LaRC-TPI (Langley Research Center - Thermoplastic Polyimide). One resin was
Falcone, A., Gerken, N. T., Hendricks, C. L., Hill, S. G.   +3 more
core   +1 more source

Feasibility Study of Radium Irradiation in Materials Testing Reactor

, 1950
R.K. Winkleblack, M. Treshow, Stuart McLain   +2 more
openalex   +2 more sources

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

The development of test methodology for testing glassy materials [PDF]

The inherent brittleness of glass invariably leads to a large variability in strength data and a time dependence in strength (i.e., static fatigue). Loading rate plays a large role in strength values.
Tucker, Dennis S.
core   +1 more source

Materials Testing Reactor Project, Argonne National Laboratory, Design Report No. 32, MTR External Air System

, 1950
C.F. Leyse
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Simplifying perovskite solar cell fabrication for materials testing: how to use unetched substrates with the aid of a three-dimensionally printed cell holder. [PDF]

R Soc Open Sci
Valdez García J, Hadadian M, Nizamov R, Mäkinen P, Lamminen N, Vivo P, Miettunen K.   +6 more
europepmc   +1 more source

Standard Reference Photographs for Liquid Penetrant Inspection [PDF]

, 2008
American Society for Testing and Materials. Philadelphia
core